During the past decade, Psychiatric Medicine Associates LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Psychiatric Medicine Associates LLC" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "LivaNova" with 2 trials sponsored, "Massachusetts General Hospital" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Cephalon" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Psychiatric Medicine Associates LLC" #1 collaborator was "Cambridge Health Alliance" with 2 trials as a collaborator, "Psychiatric Medicine Associates, L.L.C." with 2 trials as a collaborator, "University of Connecticut" with 2 trials as a collaborator, "Vanderbilt University" with 2 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Psychiatric Medicine Associates LLC" are "Major Depressive Disorder" (8 trials), "Depressive Disorder, Major" (3 trials), "Treatment Resistant Depression" (2 trials), "Bipolar Disorder" (1 trials) and "Bipolar I Depression" (1 trials). Many other conditions were trialed in "Psychiatric Medicine Associates LLC" in a lesser frequency.

Most popular intervention types in "Psychiatric Medicine Associates LLC" are "Drug" (13 trials), "Biological" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "40 Milligrams NSI-189" (1 trials), "80 Milligrams NSI-189" (1 trials), "Antidepressant + Placebo" (1 trials) and "Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Psychiatric Medicine Associates LLC" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Psychiatric Medicine Associates LLC". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Psychiatric Medicine Associates LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Psychiatric Medicine Associates LLC, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".